InvestorsHub Logo
Followers 0
Posts 1151
Boards Moderated 0
Alias Born 07/10/2003

Re: None

Friday, 07/11/2003 3:40:24 PM

Friday, July 11, 2003 3:40:24 PM

Post# of 82595
Matching Dna With Transplantation Patients- Were all going to be RICH,RICH,RICH

"Tony inedicated it took one year just to come to a working agreement,that puts us at Nov,2002. A 1 year term puts it at Nov.,2003 completed".

In November 2001, NYU's Mary Lea Johnson Richards Organ Transplantation Center agreed to provide us with informed consent qualified patient specimens and matching clinical data. We will genetically screen the specimens for markers
and/or marker sets that can be used to distinguish between drug responders and non-responders. To do this, we will employ proprietary genotyping protocols, data resources (the PHENOME SNP database) and our informatics platform. The goal of the project is to identify pharmacogenomic classifiers that could be used to match renal transplantation patients with the optimal immunosuppressant for their genetic architecture. We expect the project to take about one year to complete, and we expect the results to extend to patients for a wide range of transplantation procedures. The Mary Lea Johnson Richards Organ Transplantation Center is one of the busiest and most successful transplant programs in the United States